Costco (COST) stock could be nearing a key inflection point after a challenging holiday season, provided execs finally reveal a long-rumored profit-boosting member fee increase.
“We believe we may reach a compelling tactical inflection point at some time in the next 2-3 months ahead of a potential membership fee increase in the spring,” John Heinbockel, analyst at Guggenheim, wrote in a new client note on Tuesday.
Costco’s last membership fee increase took place on June 1, 2017. The warehouse club hiked its Gold Star membership fee by $5 to $60 a year and its Executive membership fee by $10 to $120.
According to Heinbockel’s analysis, Costco stock rose 11% on average three months prior to the last three membership fee increases in 2006, 2011, and 2017. The stock gained 15% on average six months prior to each announcement.
And rival warehouse retailer Sam’s Club, a division of Walmart (WMT), enacted a membership fee increase in Sept. 2022, which could provide Costco cover to lift its own prices.
But Costco execs have pushed back consistently on the fee increase — even at the expense of upsetting Wall Street — citing that’s not good for inflation-ravaged consumers.
Costco CFO Richard Galanti told Yahoo Finance in December the retailer isn’t ready to raise the cost of its membership. Galanti stated that the company will clearly outline any fee increases to Wall Street if and when the time comes.
With Costco pushing back on the membership fee hike, shares have traded on slowing sales growth at the warehouse king and the potential for that trend to continue in 2023 amid a sluggish economy.
Costco didn’t have a perfect November. The company reported on Nov. 30 that same-store sales growth cooled versus October, and the Street wasn’t super hot on Costco’s earnings when they hit on Dec. 8, either.
Shares are down about 8.6% in the past month versus a 6.4% drop for the S&P 500.
Meanwhile, the company is slated to reveal key December sales results later this week.
“Based on our conversations with investors, this incorporates another below-trendline comparable sales result as well as below-consensus second quarter earnings in early March,” Heinbockel added. “This lower bar would cushion the impact of any near-term shortfalls with modest likely incremental weakness, perhaps no more than 5%, despite a 17x 2023E EBITDA multiple, still one of the highest in large-cap retail.”
Brian Sozzi is an editor-at-large and anchor at Yahoo Finance. Follow Sozzi on Twitter @BrianSozzi and on LinkedIn.
Click here for the latest trending stock tickers of the Yahoo Finance platform
Click here for the latest stock market news and in-depth analysis, including events that move stocks
Read the latest financial and business news from Yahoo Finance
Download the Yahoo Finance app for Apple or Android
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and YouTube
Related Quotes
There are steps you should take to ensure you're getting a good deal when you shop and aren't missing out on any special perks that these big-box stores offer.
The move represents another step forward in terms of market penetration, a key factor for investors.
Check Point Software Technologies (NASDAQ:CHKP) has had a great run on the share market with its stock up by a…
Yahoo Finance Live’s Brian Sozzi discusses the decline in stock for Costco.
US House fails to elect new speaker to replace Nancy Pelosi
Vltava Fund, an investment management company, recently released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here. Last year, market faced a few shocks together, and the global stock market fell more than 17% as measured by the MSCI World index, and the S&P 500 index fell more than 19%. However, […]
CVS Health (CVS) closed the most recent trading day at $91.98, moving -1% from the previous trading session.
Another sell-off lurks in Tesla's stock, warns one veteran analyst.
Shares of Costco Wholesale (NASDAQ: COST) took a dive last month after the warehouse retail giant posted disappointing comparable sales for November and followed that up with a middling fiscal first-quarter earnings report. According to data from S&P Global Market Intelligence, Costco finished December down 15%, an unusually sharp slide for the solid consumer staples stock. As you can see from the chart below, Costco shares dove to start the month and continued to slide from there.
Among Meta Platforms (formerly Facebook), Amazon, Apple, Netflix, and Alphabet (formerly Google), there are two rock-solid buys and one well-known industry leader to avoid.
Bed Bath & Beyond shares see a huge reversal.
Bed Bath & Beyond may have one foot in the retail grave as its struggles continued ahead of the holiday season.
Although last year was challenging for most of Wall Street, it was an especially difficult year for growth stocks. When the curtain closed on 2022, both the growth-dependent Nasdaq Composite and the Nasdaq 100 — an index comprised of the 100 largest nonfinancial companies listed on the Nasdaq exchange — lost 33% of their value. The thumping that Nasdaq 100 stocks took last year can be a blessing in disguise for opportunistic growth seekers looking to pounce.
Silvergate Capital (NYSE: SI) reported just how hard it had to work to deal with the rapidly changing situation, and investors are more uncertain than ever about what the crypto-focused bank's future will look like and its potential impact on the entire digital asset market. Shares of Silvergate plunged 40% in premarket trading on Thursday morning, losing twice as much ground as they gained in Wednesday's trading session. Total deposits from Silvergate's digital asset customers dropped from $11.9 billion at the end of September to $3.8 billion at year-end.
Growth stocks with major industry tailwinds behind them and leading positions in their respective markets can provide life-changing returns for investors. Moderna (NASDAQ: MRNA) is a leader in mRNA technology that proved effective against COVID-19 and has a large pipeline of products in the works. Taiwan Semiconductor (NYSE: TSM) is a leading chip foundry with the technology and business model to dominate for decades.
It was a little over a year ago that Novavax (NASDAQ: NVAX) submitted its final data packages to the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine, paving the way for it to obtain Emergency Use Authorization (EUA) several months later. Could Novavax be a good contrarian investment to add to your portfolio?
Dow Jones futures extended losses Thursday on strong jobs data. Silvergate Capital crashed 40% after $8.1 billion in withdrawal.
The current rate is good, but if you hold off until just before the next change, it could be even better.
Buffett's company, Berkshire Hathaway, is much more invested in the tech sector than it used to be.
The bear run of 2022 was brutal on stock investors, in fact, it was the worst market year since the Great Recession of 2008. But – some of the Street’s strategists are predicting that this year has a recovery, or at least a partial rebound, in store. Even though the S&P 500 lost nearly 20% last year, inflation is still running at more than 7% annualized, and the Federal Reserve has bumped interest rates up to 4.25% in response, John Stoltzfus, Oppenheimer Asset Management chief investment strate
